CA
NZ
UK
AU
IND
US
West Pharmaceutical Services has formalized an updated collaboration with Daikyo Seiko, amending the cross‑license and distribution framework that originally began several years ago. The renewed agreements replace earlier versions and bring the partnership into the current reporting period.
Palvella Therapeutics (NASDAQ: PVLA) disclosed an investor presentation through a regulatory filing on July 14, 2026. The document, submitted to the U.S. Securities and Exchange Commission, serves as a corporate update for current and prospective shareholders. The filing aligns with disclosure requirements under the …
Johnson & Johnson’s upcoming earnings report is set to clarify whether the healthcare giant can extend its recent market momentum beyond sector rotation trends. The results will test investor confidence in the company’s ability to deliver sustained growth through its new product pipeline, potentially …
- Evofem Biosciences has issued a note worth $706,304 with a 12% interest rate. - The note issuance also includes a fee of $2,000. - The company's stock is traded on the OTC market under the symbol EVFM.
Jaguar Health, Inc. (NASDAQ: JAGX) disclosed that its wholly‑owned unit Napo Pharmaceuticals has secured a fresh manufacturing and supply arrangement with Alivus Life Sciences Limited. The deal ensures continued production of crofelemer, the active ingredient in the FDA‑approved drug Mytesi®, and other related products.
Kestra Medical Technologies (NASDAQ: KMTS) has finalized a $200 million senior secured term loan facility with investment funds managed by Pharmakon Advisors. The agreement, disclosed in a regulatory filing, provides a five-year financing structure to support corporate expansion and working capital needs. The facility …
Oncotelic Therapeutics (OTC: OTLC) has awarded 17,796 restricted stock units (RSUs) to its leadership team and workforce as part of its equity incentive program. The grants were extended to directors, officers, and select employees or advisors without requiring any initial payment from recipients.
Oncotelic Therapeutics, Inc. (OTC: OTLC) held a corporate presentation for its workforce and senior advisors on July 13, 2026. The briefing aimed to align internal stakeholders with the company’s strategic priorities and operational plans.
EnVVeno Medical Corp (NASDAQ: NVNO) disclosed an investor presentation to the U.S. Securities and Exchange Commission on July 14, 2026. The submission aligns with regulatory requirements under the Securities Exchange Act of 1934.
Baxter International (NYSE: BAX) has streamlined its financial reporting structure to reflect a new operating model, reducing its segments from three to two. The changes, effective for the quarter ending June 30, 2026, aim to align resource allocation and performance assessment under the leadership …
Please wait processing your request...